MedPath

Ultrasound Guided Hematoma Block in Distal Forearm Fractures

Not Applicable
Not yet recruiting
Conditions
Forearm Fracture
Interventions
Device: Ultrasound
Registration Number
NCT05537831
Lead Sponsor
State University of New York - Upstate Medical University
Brief Summary

This is a randomized control trial comparing the efficacy of ultrasound (US) guided vs landmark-guided hematoma blocks on distal forearm fractures.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Patients greater than and equal to seven years of age
  • Patients with traumatic acute distal radius/ulnar fractures with displacement that require reduction and immobilization with splinting
  • Patients that receive distal radius hematoma blocks, including those who require additional pain control adjuncts if pain control is not adequate
Exclusion Criteria
  • Prisoners
  • Pregnant women
  • Patients with altered mental status/have impaired decision-making capacity.
  • Patients with allergies to amide anesthetics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Study Intervention Group (Ultrasound)UltrasoundThe ultrasound probe will be used for real-time needle and hematoma localization using the linear probe. The hematoma block will then be performed with aseptic technique. The skin will be prepped with chlorhexidine. A 20-gauge needle will be inserted in-plane into the hematoma site. A small amount of blood will be aspirated to confirm placement and 5-10 mL of 1% lidocaine will be infiltrated.
Primary Outcome Measures
NameTimeMethod
Pain relief from landmark versus ultrasound guided hematoma blockChange in pain score from before the hematoma block to immediately after the reduction/splinting of the forearm fracture

Pain will be measured using a ten point Likert scale with zero designated as no pain and ten being the worst pain the patient can imagine. The higher score the worse the outcome.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath